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Background: The induction of miR-210-3p, a master hypoxamir, is a consistent
feature of the hypoxic response in both normal and malignant cells. However, whether
miR-210-3p acts as a circulating factor in response to a hypoxic environment remains
unknown. The current study aimed to examine the effect of a high-altitude hypoxic
environment on circulating miR-210-3p.
Methods: We examined and compared the levels of miR-210-3p using TaqMan-based
qRT-PCR in both peripheral blood cells and plasma from 84 ethnic Chinese Tibetans
residing at 3560 m, 46 newly arrived migrant Han Chinese (Tibet Han) and 82 Han
Chinese residing at 8.9m (Nanjing Han). Furthermore, we analyzed the correlations of
miR-210-3p with hematological indices.
Results: The relative concentrations of miR-210-3p to internal reference U6 in blood
cells were significantly higher in the Tibet Han group (1.01 ± 0.11, P < 0.001) and in
the Tibetan group (1.17 ± 0.09, P < 0.001) than in the Nanjing Han group (0.51 ±
0.04). The absolute concentrations of plasma miR-210-3p were also markedly elevated
in the Tibet Han group (503.54 ± 42.95 fmol/L, P = 0.004) and in the Tibetan group
(557.78 ± 39.84 fmol/L, P < 0.001) compared to the Nanjing Han group (358.39 ±
16.16 fmol/L). However, in both blood cells and plasma, miR-210-3p levels were not
significantly different between the Tibet Han group and the Tibetan group (P = 0.280,
P = 0.620, respectively). Plasma miR-210-3p concentrations were positively correlated
with miR-210-3p levels in blood cells (r = 0.192, P = 0.005). Furthermore, miR-210-3p
levels in both blood cells and plasma showed strong positive correlations with red blood
cell counts and hemoglobin and hematocrit values.
Conclusion: These data demonstrated, for the first time, that miR-210-3p might act as
a circulating factor in response to hypoxic environments and could be associated with
human adaptation to life at high altitudes.
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INTRODUCTION
MicroRNAs (miRNAs), which are endogenously expressed
small noncoding RNAs, regulate gene expression at the post-
transcriptional level by either degrading or blocking the
translation of messenger RNA targets. Recent studies have
strongly suggested that miRNAs act as critical mediators of
the hypoxic response (Yan et al., 2009; Nallamshetty et al.,
2013; Rupaimoole et al., 2014). miR -210 represents a major
hypoxia-inducible miRNA also known as a hypoxamir, which is
ubiquitously expressed in a broad range of cells (Huang et al.,
2010; Chan et al., 2012; Huang and Zuo, 2014; Qu et al., 2014).
Emerging evidence has demonstrated that the induction of miR-
210-3p, as a robust target of hypoxia-inducible factors (HIFs),
is a consistent feature of the hypoxic response in both normal
and malignant cells, and its overexpression has been detected in a
variety of diseases with hypoxic components (Devlin et al., 2011;
Kelly et al., 2011; Cicchillitti et al., 2012; Hale et al., 2014; Qu et al.,
2014; Wang et al., 2014). miR-210-3p has been reported as the
master regulator of hypoxic tumor response in various cancers
(Huang et al., 2009; Greither et al., 2010) by disturbing mitosis
through targetingmultigenes involved inmitotic progression (He
et al., 2013). More importantly, miR-210-3p was identified as
deeply involved in the erythroid phenotype. Several functions
related with erythroid cells were demonstrated to be regulated
by miR-210-3p, including maturation and proliferation of early
erythroid cells, expression of fetal g-globin genes and enucleation
(Kosaka et al., 2008; Bianchi et al., 2009). Recently, our group
and others have discovered that miRNAs are stably secreted
into the bloodstream, as well as in response to tissue injury
and other pathological conditions (Chen et al., 2008; Lawrie
et al., 2008; Mitchell et al., 2008; Zhang et al., 2010; Wang
et al., 2015; Wronska et al., 2015). Increases in the plasma-based
expression of miR-210-3p have been reported in the context
of various cancers and other hypoxia-induced pathological
conditions (Raitoharju et al., 2011; Greco et al., 2012; Whitehead
et al., 2013; Huang and Zuo, 2014; Ono et al., 2015). However,
whether miR-210-3p might act as a circulating factor in response
to hypoxic environments has barely been explored.
High-altitude hypoxia is caused by decreased barometric
pressure, which results in reduced arterial oxygen content that,
therefore, exerts formidable physiological stress on the human
body. The extreme environmental conditions experienced at
high altitudes challenge the ability of humans to adapt and/or
acclimatize. Elevated erythropoietin (EPO), erythrocytes, and
hemoglobin (HGB) and increased angiogenesis are common
responses to hypoxic stress, which allow for more efficient
oxygen utilization. Individuals from low-altitude populations
(such as the Han Chinese) who move to live at higher
altitudes suffer from a number of potentially lethal diseases
specifically related to the low levels of oxygen (Wu and
Miao, 2001; Wu, 2004; León-Velarde et al., 2005), and they
often struggle to reproduce at these altitudes Moore et al.,
2001a,b; Julian et al., 2009, whereas populations living in
high-altitude regions, such as the Tibetan people of Chinese
Tibet, exhibit a unique suite of physiological changes, including
circulatory, respiratory, and hematological adaptations to life
with decreased available oxygen at high altitudes (Ge et al.,
1994; Chen et al., 1997; Beall, 2007). Genetic selection for
high altitude adaptation and variations in single nucleotide
polymorphisms between Tibetans and lowlander populations
have been extensively documented (Beall, 2007; Simonson
et al., 2010; Yi et al., 2010). An attenuated response to low
oxygen, lower levels of erythrocyte, increased blood flow due
to reduced viscosity of the blood and changes in respiratory
physiology correlate well with genetic selection. However, very
little research has been devoted to the identification of the
miRNAs responsible for the adaptation/acclimatization to high
altitude hypoxia.
Therefore, in the present study, we examined and compared
the expression levels of miR-210-3p in both plasma and
peripheral blood cells samples from Han Chinese subjects
residing in Nanjing, which lies at sea level (Nanjing Han),
Han Chinese who have recently immigrated from the plains to
placeTibet (Tibet Han) and ethnic Chinese Tibetans. We also
analyzed the correlations betweenmiR-210-3p and hematological
indices.
METHODS
Study Design and Subjects
The present study enrolled 84 healthy, native Tibetans volunteers
who resided in Nêdong, a county of Lhoka prefecture in the
Tibet Autonomous Region, at an altitude of 3560m (Tibetan),
46 ethnic Han Chinese who immigrated 1–2 years ago (mean
of 17 months) from the plains of East China to Nêdong (Tibet
Han) and 82 Han Chinese residing in Nanjing (Nanjing Han), a
city located in East China, at an altitude of 8.9 m. The Tibet Han
and Tibetan participants were recruited from among individuals
reporting for routine health checkups at the Forty-First Hospital
of the PLA in Nêdong, China, and the Nanjing Han participants
were recruited from among individuals who had visited the
Jinling Hospital in Nanjing, China, for routine checkups between
2013 and 2014. All of the participants were healthy.
All of the blood samples were collected in EDTA tubes
using a standard operating procedure. Written informed consent
was obtained from all of the participants prior to the study.
The study protocol was approved by the ethics committees
of Jinling Hospital and the Forty-First Hospital of PLA. The
study was performed in accordance with the Declaration of
Helsinki.
Hematology and Plasma EPO Analysis
Hematological indices, including red blood cell count (RBC),
HGB and hematocrit (HCT), were measured with XE-2100
analyzers (Sysmex, Kobe, Japan) with commercial reagents,
immediately after drawing a venous blood sample. Plasma
EPO concentration was measured with commercial enzyme-
linked immunosorbent assay (ELISA) kits (Cusabio, Wuhan,
China).
RNA Isolation and qRT-PCR Assay of
miR-210-3p in Plasma and Peripheral
Blood Cells
RNA from the plasma and peripheral blood cell samples was
prepared for qRT-PCR assay at roughly the same time. Total
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RNA was extracted from 100µL of plasma with a 1-step
phenol/chloroform purification protocol, as previously described
(Wang et al., 2015). A TaqMan probe-based qRT-PCR assay of
plasmamiR-210-3p was conducted on a 7300 Sequence Detection
System (Applied Biosystems, Foster City, CA, USA) according
to the manufacturer’s instructions, with a minor modification as
described previously (Zhang et al., 2010). All of the reactions
were run in triplicate, and the average Cq values were calculated.
To control for variability in the RNA extraction and purification
procedures, an exogenous reference gene, plantmiRNAMIR2911
(5′-GGCCGGGGGACGGGCUGGGA), was spiked into each
plasma sample at a final concentration of 106 fmol/L during RNA
isolation. The Cq values of MIR2911 remained constant among
the three studied groups (Figure S1). Relative concentrations of
miR-210-3p were normalized to MIR2911 and were calculated
using the comparative Cq method (2−1Cq). △ Cq was calculated
by subtracting the Cq values of MIR2911 from the Cq values
of the miR-210-3p. The relative concentration of miR-210-
3p to MIR2911 was calculated using the equation 2−1Cq.
Furthermore, we calculated the absolute concentration of miR-
210-3p from calibration curve developed with corresponding
synthetic single-strand miR-210-3p oligonucleotide as previously
described (Liu et al., 2011, 2012; Chen et al., 2012; Luo
et al., 2013). The standard curve was prepared by ten-fold
serial dilution of synthetic miR-210-3p oligonucleotide (TaKaRa,
Dalian, China) from 100 fmol/L to 103 pmol/L, and the level
of this miR-210-3p oligonucleotide was assessed by qRT-PCR
assay. The resulting Cq values were plotted vs. the log10 of the
amount of the synthetic miR-210-3p (Figure S2). Each sample
and each dilution of the calibrator were run in triplicate for
analysis.
The total RNA of peripheral blood cells was extracted with
TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), according to
the manufacturer’s instructions. The concentration and quality
of the extracted RNA were determined with a spectrophotometer
(Eppendorf, Hamburg, Germany) at 260 nm and 280 nm.
U6 was used as an internal reference for the qRT-PCR
analysis of miR-210-3p in peripheral blood cells because
its Cq values did not show differences among the three
studied groups (Figure S3). The relative content of miR-
210-3p was normalized to U6 and was calculated using the
comparative Cq method (2−1Cq) with the same method
described above.
Data Analysis
All of the statistical analyses were performed using the SPSS
software, version 17.0. The concentrations of miR-210-3p and
EPO are presented as the mean ± SEM, and other variables
are expressed as the mean ± SD. The differences in variants
among groups were analyzed by one-way ANOVA, and the
differences between groups were subsequently determined by
the nonparametric Mann-Whitney U-test. The two-sided x2 test
was used to compare sex distributions between two groups. A
P < 0.05 was considered statistically significant. Spearman’s
rank correlation analysis was conducted to analyze correlations
between variables.
RESULTS
Demographic and Hematological Features
of All Participants
The demographic and hematological features of the three studied
groups are summarized in Table 1. There were no significant
differences in age or sex distributions among the Nanjing Han,
Tibet Han and Tibetan groups. The RBC, HGB, and HCT values
of both men and women, however, were significantly increased
(P-values ranging from <0.05 to <0.001) in the Tibet Han
group compared with the Nanjing Han group. The HGB and
HCT values of both men and women (P = 0.001), along with
the women’s RBC values (P = 0.02), were also significantly
higher in the Tibetan group than in the Nanjing Han group.
Furthermore, we compared these parameters between the Tibet
Han group and the Tibetan group, and observed that the RBC,
HGB, and HCT values were significantly increased in the Tibet
Han men compared to the Tibetan men (P = 0.005, P =
0.014, and P = 0.024, respectively). Similarly, the levels of RBC,
HGB, and HCT were also higher in the Tibet Han women
than in the Tibetan women; however, these differences did not
achieve statistical significance. In addition, we evaluated the
concentrations of plasma EPO in some of the studied individuals.
As a result, the plasma concentrations of EPO in both men
and women were also significantly increased in the Tibet Han
group and the Tibetan group compared with the Nanjing Han
group (P < 0.05); however, the EPO concentration was not
different between the Tibet Han group and the Tibetan group
(Table 1).
Plasma miR-210-3p Concentrations
We measured the concentrations of miR-210-3p in plasma
samples from all of the participants by qRT-PCR assay.
The relative concentrations of miR-210-3p to MIR2911 were
markedly elevated in the Tibet Han and Tibetan groups as
compared with the Nanjing Han group (P < 0.001) (Figure S4).
The plasma absolute concentrations of miR-210-3p were also
significantly higher in the Tibet Han and Tibetan groups than
in the Nanjing Han group (P = 0.004, P < 0.001, respectively)
(Table 2). However, no marked difference in plasma miR-210-3p
concentration was observed between the Tibet Han group and
the Tibetan group (P = 0.620).
Expression Level of miR-210-3p in
Peripheral Blood Cells
Furthermore, we determined miR-210-3p expression levels in
peripheral blood cells using qRT-PCR assay. The results of
miR-210-3p in blood cells were in agreement with those of
plasma samples, showing that the expression level of miR-210-
3p was markedly increased in the Tibet Han and Tibetan groups
compared to the Nanjing Han group (1.98-fold increase, P <
0.001; 2.29-fold increase, P < 0.001, respectively) (Table 2).
Similarly, the miR-210-3p level was also higher in the Tibetan
group than in the Tibet Han group; however, the difference did
not achieve statistical significance (P = 0.280).
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TABLE 1 | Demographic and hematological features of the Nanjing Han, Tibet Han, and Tibetan groupsa.
Variable Nanjing Han Tibet Han Tibetan Pb Pc Pd
n 82 46 84
Sex 0.142e 0.163e 0.763e
Male 37 27 47
Female 45 19 37
Age, years 33.25± 9.06 33.00± 10.57 35.47±10.07 0.892 0.170 0.146
Male 34.59± 7.64 32.11± 10.15 36.42±10.58 0.309 0.387 0.065
Female 31.98± 9.97 34.26± 11.29 34.30±9.27 0.405 0.298 0.991
HEMATOLOGICAL INDICES
RBC (1012/L) 4.73± 0.45 5.31± 0.70 4.86±0.71 <0.001 0.404 0.002
Male 5.08± 0.34 5.59± 0.67 5.01±0.85 0.003 0.931 0.005
Female 4.44± 0.28 4.90± 0.53 4.67±0.43 0.007 0.02 0.254
HGB (g/L) 138.73± 13.82 170.33± 21.85 158.63±21.85 <0.001 <0.001 0.032
Male 150.00± 10.75 179.15± 19.73 164.38±21.65 <0.001 0.001 0.014
Female 129.47± 7.90 157.79± 18.68 145.92±15.51 <0.001 <0.001 0.077
HCT (%) 38.28± 6.57 50.31± 6.60 46.58±6.59 <0.001 <0.001 0.002
Male 39.46± 7.88 52.92± 6.31 48.49±7.31 <0.001 <0.001 0.024
Female 37.31± 5.15 46.61± 5.20 43.60±34.26 <0.001 <0.001 0.128
EPO (mIU/ml) 95.52± 5.97 159.11± 13.87 184.07±14.74 <0.001 <0.001 0.350
n (male/female) 60 (24/26) 40 (21/19) 50 (28/22) 0.461e 0.548e 0.832e
Male 123.66± 10.78 191.12± 18.51 178.00±18.75 0.010 0.047 0.946
Female 60.32± 6.08 130.60± 19.42 191.78±23.92 0.001 <0.001 0.063
RBC, red blood cell counts; HGB, hemoglobin; HCT, hematocrit; EPO, erythropoietin. aData are presented as mean ± standard deviation, EPO are presented as mean ± standard
error. bTibet Han vs. Nanjing Han; c Tibetan vs. Nanjing Han; dTibetan vs. Tibet Han. eTwo-sided χ2 test.
TABLE 2 | The concentrations of miR-210-3p in plasma and peripheral blood cells from Nanjing Han, Tibet Han, and Tibetan determined by qRT-PCR
assaya.
miR-210-3p Nanjing Han Tibet Han Fold changeb Pb Tibetan Fold changec Pc Pd
Plasma 358.39 ± 16.16 503.54 ± 42.95 1.41 0.004 557.78 ± 39.84 1.56 <0.001 0.620
Blood cells 0.51 ± 0.04 1.01 ± 0.11 1.98 <0.001 1.17 ± 0.09 2.29 <0.001 0.280
aThe absolute concentration of miR-210-3p in plasma is presented as the mean± SEM (fmol/L), and the relative concentration of miR-210-3p to U6 in peripheral blood cells is presented
as the mean ± SEM. bTibet Han/Nanjing Han. cTibetan/Nanjing Han.dTibetan/Tibet Han. FC, fold change.
Correlation between Plasma miR-210-3p
and miR-210-3p in Peripheral Blood Cells
Subsequently, we used Spearman’s rank correlation analysis to
test for the correlations between the relative concentrations of
miR-210-3p toMIR2911 in plasma and relative concentrations of
miR-210-3p to U6 in blood cell in all of the studied individuals.
As shown in Figure 1, a positive correlation was observed
between the two (r= 0.192, P= 0.005). This result indicated that
plasma miR-210-3p might partly originate from peripheral blood
cells.
Relationships of miR-210-3p with
Hematological Indices and EPO
Next, we evaluated whether levels of miR-210-3p in plasma
or in peripheral blood cells were related to hematological
values and plasma EPO concentrations. Consequently, the
absolute concentrations of miR-210-3p in plasma and the relative
concentrations of miR-210-3p to U6 in blood cells showed
significantly positive correlations with RBC, HGB and HCT
values (Figures 2A–C, 3A–C) in all of the studied subjects.
The plasma level of miR-210-3p also exhibited a significantly
positive correlation with plasma EPO concentration (Figure 2D);
however, no significant correlation was found between miR-
210-3p levels in blood cells and plasma EPO concentrations
(Figure 3D).
DISCUSSION
Hypoxia occurs in many physio-pathological processes, such as
rapid tissue growth and acute and chronic ischemia, as well
as at high altitudes. Previous data have indicated that hypoxia
leaves a specific mark on miRNA profiles in a variety of cell
types, with a critical contribution of HIF (Kulshreshtha et al.,
2007). miR-210 is a well-known miRNA induced under hypoxic
condition in several types of tissues and cells, and it contributes
to cellular adaptation to hypoxic environments (Huang et al.,
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FIGURE 1 | Spearman’s rank correlation between miR-210-3p in
plasma and in peripheral blood cells.
2010). Various of miR-210 targets have been identified, pointing
to their roles in mitochondrial metabolism, angiogenesis, DNA
damage response, apoptosis, and cell survival (Huang and Zuo,
2014). For example, the receptor tyrosine kinase ligand Ephrin-
A3 (EFNA3) was identified as a miR-210 target for promoting
the angiogenic properties of vascular endothelial growth factor
(VEGF) (Fasanaro et al., 2008). E2F transcription factor 3
(E2F3) and fibroblast growth factor receptor-like1 (FGFRL1)
were identified as miR-210 targets involved in cell cycle control
(Nakada et al., 2011; Tsuchiya et al., 2011). In this study, we
investigated the influence of high altitude hypoxic environments
on miR-210-3p in human plasma and peripheral blood cells.
We found that miR-210-3p in both plasma and blood cells was
significantly higher in samples from either Tibet Han subjects
or from Tibetan subjects than in samples from Nanjing Han
subjects. To the best of our knowledge, this report is the first
demonstrating that a high-altitude hypoxic environment has
remarkable influences on human circulating miR-210-3p.
Since the discovery of circulating miRNA, their potential as
molecular biomarkers for the diagnosis of various pathologic
conditions has been explored. However, little is known about the
origin of the extracellular miRNAs and what factors influence
the levels of circulating miRNAs (Machado et al., 2015). Some
studies have demonstrated that circulating miRNAs derive from
a variety of sources. They derive not only from circulating
blood cells but also from other injured cells affected by diseases
(Chen et al., 2008). In this study, we observed a correlation in
expression of miR-210-3p between the plasma and peripheral
blood cells. But the origin of plasma miR-210-3p is not clear.
Considering that hypoxia can affect the expression of miR-
210-3p in a variety of cells, such as peripheral blood cells as
observed in this study and endothelial cells (Fasanaro et al.,
2008), we speculate that the increased plasma miR-210-3p
might derive from these cells and other tissue cells in chronic
hypoxic environments. The mechanism of miRNA secreted from
cells to the blood circulation is not yet entirely clear. Active
secretion by cells is a major source of circulating miRNAs;
some miRNAs might also leak out of injured cells into the
circulating blood (Ji et al., 2009; Iguchi et al., 2010; Ogawa
et al., 2010; Wang et al., 2010). We speculate that miR-210-
3p might mainly be secreted by the above-mentioned cells via
cell-derived microvesicles or exosomes, or as microvesicles-free
miRNAs into the circulation (Zen and Zhang, 2012) in response
to hypoxic conditions, resulting in the increase of plasma miR-
210-3p level. However, future studies are needed to clarify this
issue.
Erythropoiesis, which is the process of erythroid production,
is controlled by several factors, including oxygen levels. In the
present study, we found that RBC, HGB, HCT values and
plasma EPO concentrations of both men and women were
significantly increased in the Tibet Han group compared with
the Nanjing Han group. The HGB, HCT, and EPO values
of both men and women, along with the RBC values in
women, were also significantly higher in the Tibetan group
than in the Nanjing Han group. The significance of elevated
hematological indices in high altitude adaptation remains
controversial. Some investigators believe that erythremia is a
compensatory mechanism for hypoxemia at moderate altitudes
and therefore that high levels of HGB represent a physiologic
response and might be beneficial, but with increasing altitude,
HGB and HCT can become excessive, losing their efficiency to
serve the purpose of protecting the venous PO2 (León-Velarde
et al., 2000). However, others believe that the polycythemia
is pathological rather than indicative of adaptability (Garruto
and Dutt, 1983), and even a slight increase in erythrocytosis
will not have any physiological effect (Winslow et al., 1985).
Previous studies have observed that the physiological response
to low oxygen differs between Tibetans and individuals of low-
altitude origin. For most individuals, acclimatization to low
oxygen involves an increase in blood HGB levels. However,
in Tibetans, the increase in HGB levels was limited. Further,
the ability of Tibetans to adapt well to high altitude hypoxic
environments might be a result of natural selection (Yi et al.,
2010; Huerta-Sánchez et al., 2014). The same phenomenon
was observed in our study, in which we compared these
hematological parameters between the Tibet Han group and
the Tibetan group and observed that those parameters were
significantly increased in the Tibet Han men compared to the
Tibetan men. Similarly, the levels of RBC, HGB, and HCT
were also higher in Tibet Han women than in Tibetan women;
however, the differences did not achieve statistical significance.
Our results were agreement with previous studies showing that
the HGB, HCT, and RBC were higher in men than in women
for both Tibetan and Han subjects. However, the difference
between men and women was less for Tibetans than for Han
Chinese. Additionally, the difference was particularly striking
among the Han men, who appeared to have much higher HGB
values than the Tibetan men (Wu et al., 2014). It has been
reported that post-menopausal Han women have higher HGB
and HCT concentrations than pre-menopausal women (León-
Velarde et al., 1997; Wu et al., 2014). Therefore, we speculated
that ovarian hormones could have certain effects on the limit of
the erythropoietic response to altitude and render Han women
able to adapt to high altitude hypoxic environments better than
Han men.
Recent studies are evidenced that the miRNAs are key
regulators of all stages of hematopoiesis and hematopoietic
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FIGURE 2 | The correlations of absolute concentrations of plasma miR-210-3p with hematological indices and plasma EPO concentrations (n = 212).
(A–D) Correlations of plasma miR-210-3p concentrations with red blood cell count (RBC) and with hemoglobin (HGB), hematocrit (HCT), and plasma erythropoietin
(EPO) values, calculated by Spearman’s rank correlation analysis.
FIGURE 3 | The correlations of miR-210-3p expression levels in peripheral blood cells with hematological indices and plasma EPO concentrations
(n = 212). (A–D) Correlations of miR-210-3p expression levels in blood cells with red blood cell count (RBC) and with hemoglobin (HGB), hematocrit (HCT), and
plasma erythropoietin (EPO) values, calculated by Spearman’s rank correlation analysis.
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disorders (Undi et al., 2013; Raghuwanshi et al., 2015).
Several studies have shown significant role of miRNA in
hematopoietic system markedly increased to more than 500
as listed in miRBase (www.mirbase.org) (Chen et al., 2004).
Some miRNAs were reported to prevent the differentiation of
early stage progenitor cells, or to regulate the terminal stages
of hematopoietic development (Georgantas et al., 2007). miR-
210-3p has also been reported to regulate the maturation and
proliferation of early erythroid cells (Kosaka et al., 2008),
and the expression of fetal g-globin genes and enucleation
(Bianchi et al., 2009). A recent study demonstrated that
hypoxia induced differentiation of both K562 and β-thalassemic
erythroid progenitor cells, and this induction was at least
in part mediated by miR-210 (Sarakul et al., 2013). In this
study, we evaluated the correlations between miR-210-3p and
hematological parameters, and we found that miR-210-3p in both
plasma and blood cells showed strong and significant positive
correlations with RBC, HGB, and HCT. In addition, plasma
miR-210-3p concentrations were also found to be related to
plasma EPO concentrations. Our study further demonstrated a
relationship between erythropoiesis and miR-210-3p in hypoxia
environments.
CONCLUSIONS
We defined that the levels of miR-210-3p in plasma and blood
cells were affected by high altitude hypoxic environments and
that miR-210-3p might act as a circulating factor in response
to hypoxic environments. Furthermore, we demonstrated
strong positive relationships of circulating miR-210-3p with
hematological parameters. Our results provided additional
information regarding the molecular mechanisms of human
adaptation to life at high altitude hypoxia, andmiR-210-3p might
contribute to this process.
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